Receipt of Observation Letter with no adverse observations / no objection from the Stock Exchanges in relation to the Scheme of amalgamation between Dr. Agarwal s Eye Hospital Limited and Dr. Agarwal s Health Care Limited and their respective shareholders and creditors
AGARWALEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Agarwal's Health Care Limited has received an observation letter from the Stock Exchanges (NSE/BSE) with no adverse observations and no objection to its proposed scheme of amalgamation with Dr. Agarwal's Eye Hospital Limited. This is an important regulatory milestone — the stock exchanges have cleared the merger proposal after reviewing it. The scheme now moves toward the next stage, which typically involves seeking approval from the National Company Law Tribunal (NCLT) and shareholders/creditors of both companies. Dr. Agarwal's Eye Hospital Limited will merge into Dr. Agarwal's Health Care Limited under the proposed arrangement. No swap ratio or other financial details have been disclosed in this particular filing.
This is a positive procedural step for the merger, but the deal is not yet final — NCLT and shareholder approvals are still required. Existing investors in Dr. Agarwal's Eye Hospital Limited should watch for the swap ratio announcement, while Dr. Agarwal's Health Care Limited shareholders will see the eye hospital business consolidated into the listed entity once the scheme becomes effective.